NanoSyrinx, a spin out from the University of Warwick, are using viruses to help inject therapeutics directly into the interior of cells, revolutionising how medicines are administered on a nanoscopic scale. Ben talks to their CEO Dr Joe Healey about their bacteria based platform, the recent seed investment raise of £6m and how his interest in being a CEO evolved.
Podden och tillhörande omslagsbild på den här sidan tillhör
Spin Up Science. Innehållet i podden är skapat av Spin Up Science och inte av,
eller tillsammans med, Poddtoppen.
